David Larsen
Stock Analyst at BTIG
(2.13)
# 2,899
Out of 5,057 analysts
85
Total ratings
38.57%
Success rate
-2.16%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $4.16 | +284.62% | 7 | Nov 7, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $45 | $21.91 | +105.39% | 2 | Nov 7, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8 → $9 | $6.31 | +42.63% | 1 | Nov 6, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Buy | $85 | $36.05 | +135.78% | 2 | Nov 4, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $30 → $41 | $31.75 | +29.13% | 3 | Oct 29, 2025 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.08 | +127.27% | 1 | Oct 21, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $291.70 | +16.56% | 3 | Oct 17, 2025 | |
| CYRX Cryoport | Maintains: Buy | $10 → $15 | $8.76 | +71.33% | 4 | Sep 18, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | n/a | $2.35 | - | 4 | Sep 5, 2025 | |
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $17.22 | +45.18% | 3 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $49.72 | +60.90% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $24.42 | +14.66% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $99.50 | +30.65% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $23.50 | +31.91% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $223.55 | +16.31% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.72 | +157.35% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.04 | +573.08% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $4.62 | +203.03% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.00 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.56 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.60 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.75 | +47.37% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.07 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $3.99 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $206.06 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $846.24 | -81.09% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.34 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $79.24 | +7.27% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $2.93 | +684.98% | 1 | Nov 2, 2017 |
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $4.16
Upside: +284.62%
Astrana Health
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $21.91
Upside: +105.39%
LifeStance Health Group
Nov 6, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.31
Upside: +42.63%
Hims & Hers Health
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $36.05
Upside: +135.78%
BrightSpring Health Services
Oct 29, 2025
Maintains: Buy
Price Target: $30 → $41
Current: $31.75
Upside: +29.13%
The Oncology Institute
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.08
Upside: +127.27%
Veeva Systems
Oct 17, 2025
Reiterates: Buy
Price Target: $340
Current: $291.70
Upside: +16.56%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.76
Upside: +71.33%
Health Catalyst
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.35
Upside: -
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $17.22
Upside: +45.18%
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $49.72
Upside: +60.90%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $24.42
Upside: +14.66%
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $99.50
Upside: +30.65%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $23.50
Upside: +31.91%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $223.55
Upside: +16.31%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.72
Upside: +157.35%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.04
Upside: +573.08%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $4.62
Upside: +203.03%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $35.56
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.75
Upside: +47.37%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.07
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $3.99
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $206.06
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $846.24
Upside: -81.09%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.34
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $79.24
Upside: +7.27%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $2.93
Upside: +684.98%